Coenzyme Q10 for Gulf War Illness: A Replication Study

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Gulf War Syndrome, Persian Gulf Syndrome, Mitochondrial Disorder, Respiratory Chain

In brief

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

Key facts

Study ID

NCT06515184

Run by

University of California, San Diego

People needed

192

Starts

2024-09-13

Expected to finish

2027-12-01

Last updated by the study team

2026-05-01

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets both CDC and Kansas deployment and symptom inclusion criteria.
• Does not have a disqualifying condition.
• Able to travel to a local Quest facility for study blood draws.
• Adequate internet access to allow ZoomPro visit participation and remote survey completion.
• Health prior to the Gulf War rated as "very good" or "excellent" (to exclude persons who may have had other health conditions with different mechanisms as the cause of their symptoms).
• Willing to defer initiation of discretionary treatments or supplements during the expected course of study participation.

You may not qualify if…

• Participating in another clinical trial.
• Still-evolving adverse effects following another medication or health condition, such as covid or fluoroquinolone use.
• On Coumadin/ warfarin.
• Unable to participate for the required duration of the study.

Where it is running

• UC San Diego — La Jolla, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.